Bioventix (LON:BVXP) Reaches New 52-Week Low – Should You Sell?

Shares of Bioventix PLC (LON:BVXPGet Free Report) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as GBX 2,650 ($34.36) and last traded at GBX 2,698 ($34.98), with a volume of 24322 shares changing hands. The stock had previously closed at GBX 2,775 ($35.98).

Bioventix Trading Up 2.6 %

The company has a 50 day simple moving average of GBX 2,971.52 and a 200 day simple moving average of GBX 3,433.18. The stock has a market capitalization of £140.75 million, a PE ratio of 17.38 and a beta of 0.35.

About Bioventix

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.

Recommended Stories

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.